Works matching DE "CASTRATION-resistant prostate cancer"
Results: 2814
PSMA-targeted therapy well tolerated in men with mCRPC.
- Published in:
- Urology Times, 2020, v. 48, n. 2, p. 13
- By:
- Publication type:
- Article
Accelerating Cellular Uptake with Unnatural Amino Acid for Inhibiting Immunosuppressive Cancer Cells.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 30, p. 1, doi. 10.1002/chem.202400691
- By:
- Publication type:
- Article
Role of meprin metalloproteases in metastasis and tumor microenvironment.
- Published in:
- Cancer & Metastasis Reviews, 2019, v. 38, n. 3, p. 347, doi. 10.1007/s10555-019-09805-5
- By:
- Publication type:
- Article
From testosterone to mitochondria: unveiling the metabolic consequences of abiraterone therapy.
- Published in:
- World Journal of Urology, 2025, v. 43, n. 1, p. 1, doi. 10.1007/s00345-025-05457-z
- By:
- Publication type:
- Article
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer.
- Published in:
- World Journal of Urology, 2024, v. 43, n. 1, p. 1, doi. 10.1007/s00345-024-05388-1
- By:
- Publication type:
- Article
Influence of metastatic sites and burden on oncological outcomes in patients progressing to metastatic castration resistant prostate cancer.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05341-2
- By:
- Publication type:
- Article
Enzalutamide versus abiraterone acetate in the development of new-onset or worsening type 2 diabetes mellitus in patients with metastatic castration-resistant prostate cancer: EVADE study.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05280-y
- By:
- Publication type:
- Article
Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05188-7
- By:
- Publication type:
- Article
Abiraterone-Induced Endocrinopathies.
- Published in:
- JCEM Case Reports, 2023, v. 1, n. 2, p. 1, doi. 10.1210/jcemcr/luad039
- By:
- Publication type:
- Article
Hypotheses And Current Treatment Options for Castration Resistance in Prostate Cancer.
- Published in:
- International Journal of High School Research, 2024, v. 6, n. 4, p. 47, doi. 10.36838/v6i4.8
- By:
- Publication type:
- Article
Foreword.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 2, p. 1
- By:
- Publication type:
- Article
Redefining Treatment Paradigms in Metastatic Castration-resistant Prostate Cancer: A Comprehensive Analysis of Cabozantinib and Atezolizumab Based on the CONTACT-02 Study Results.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 2, p. 45, doi. 10.17925/OHR.2024.20.2.3
- By:
- Publication type:
- Article
Literature Review on The Evolutional Steps in Updating Gleason Grading System of Prostatic Adenocarcinoma.
- Published in:
- Kerbala Jorunal of Medicine, 2020, v. 13, n. 1, p. 2253
- By:
- Publication type:
- Article
[<sup>177</sup>Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP).
- Published in:
- Internal Medicine Research Review, 2021, n. 70, p. 4
- By:
- Publication type:
- Article
Physician and Patient Preferences for the Treatment of Metastatic Castration-Sensitive and Castration-Resistant Prostate Cancer: A Best-Worst Scaling Study in Japan.
- Published in:
- Oncology & Therapy, 2025, v. 13, n. 1, p. 217, doi. 10.1007/s40487-025-00326-6
- By:
- Publication type:
- Article
Schizophrenia and self-castration: a case report.
- Published in:
- European Psychiatry, 2020, v. 63, p. S243
- By:
- Publication type:
- Article
Superscan on <sup>68</sup>Ga PSMA PET/CT in patients with metastatic prostate carcinoma: A case series.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Finding the optimal treatment sequence in metastatic castration-resistant prostate cancer – case report.
- Published in:
- Oncolog-Hematolog, 2023, n. 64, p. 34
- By:
- Publication type:
- Article
A case report of fulminant hepatitis due to docetaxel in breast cancer .
- Published in:
- Oncolog-Hematolog, 2022, n. 59, p. 22
- By:
- Publication type:
- Article
Role of Healthcare Professionals and Sociodemographic Characteristics in COVID-19 Vaccination Acceptance among Uro-Oncology Patients: A Cross-Sectional Observational Study.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 911, doi. 10.3390/vaccines11050911
- By:
- Publication type:
- Article
Therapeutic Cancer Vaccines and Their Future Implications.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 660, doi. 10.3390/vaccines11030660
- By:
- Publication type:
- Article
Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 786, doi. 10.3390/vaccines9070786
- By:
- Publication type:
- Article
Palliative Re-Irradiation of Bone Metastases - Case Report.
- Published in:
- Medicina Moderna, 2020, v. 27, n. 4, p. 313, doi. 10.31689/rmm.2020.27.4.313
- By:
- Publication type:
- Article
Management of systemic prostate cancer: current algorithm from castration sensitive to castration resistant setting.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2022, v. 26, n. 22, p. 8481
- By:
- Publication type:
- Article
MicroRNA-144-3p inhibits cell proliferation and promotes apoptosis in castration-resistant prostate cancer by targeting CEP55.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2018, v. 22, n. 22, p. 7660
- By:
- Publication type:
- Article
Study on the influence of metformin on castration-resistant prostate cancer PC-3 cell line biological behavior by its inhibition on PLCε gene-mediated Notch1/Hes and androgen receptor signaling pathway.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2017, v. 21, n. 8, p. 1918
- By:
- Publication type:
- Article
Castration-induced upregulation of insulin-like growth factor binding protein-5 potentiates IGF-1 and accelerates androgen-independent progression in prostate cancer.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2000, v. 3, n. 1, p. S16, doi. 10.1038/sj.pcan.4500440
- By:
- Publication type:
- Article
Can PD-1 expression in prostate cancer help to predict response to single ADT in an Indonesian population?
- Published in:
- Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2024, v. 41, n. 3, p. 474, doi. 10.52142/omujecm.41.3.4
- By:
- Publication type:
- Article
Therapeutic Outcomes of <sup>177</sup>Lu-PSMA Targeted Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Single-Center Study.
- Published in:
- Asia Oceania Journal of Nuclear Medicine & Biology, 2023, v. 11, n. 1, p. 23, doi. 10.22038/AOJNMB.2022.64964.1454
- By:
- Publication type:
- Article
Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castrationresistant prostate cancer.
- Published in:
- Asia Oceania Journal of Nuclear Medicine & Biology, 2023, v. 11, n. 1, p. 13, doi. 10.22038/AOJNMB.2022.67136.1468
- By:
- Publication type:
- Article
Estimation of the lower limits for feasible Ra-223 SPECT imaging: a Monte Carlo simulation study.
- Published in:
- Asia Oceania Journal of Nuclear Medicine & Biology, 2021, v. 9, n. 2, p. 131, doi. 10.22038/AOJNMB.2021.54386.1372
- By:
- Publication type:
- Article
Exploring the anticancer potential of sulfate-hydroxy-butanone derivatives: insights from experimental and quantum chemical investigations.
- Published in:
- Zeitschrift für Physikalische Chemie, 2023, v. 237, n. 10, p. 1643, doi. 10.1515/zpch-2023-0307
- By:
- Publication type:
- Article
Challenges in the solution phase synthesis of PSMA-11 and PSMA-617: organic ligands for radiopharmaceutical preparations in prostate cancer medication.
- Published in:
- Radiochimica Acta, 2024, v. 112, n. 9, p. 651, doi. 10.1515/ract-2024-0280
- By:
- Publication type:
- Article
Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with de novo metastatic prostate cancer.
- Published in:
- International Journal of Urology, 2019, v. 26, n. 3, p. 426, doi. 10.1111/iju.13870
- By:
- Publication type:
- Article
Permanent <sup>125</sup>I prostate brachytherapy for castration‐resistant prostate cancer.
- Published in:
- International Journal of Urology, 2019, v. 26, n. 2, p. 278, doi. 10.1111/iju.13866
- By:
- Publication type:
- Article
Response to Editorial Comment to Impact of prior local therapy on overall survival in men with metastatic castration‐resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Editorial Comment to Impact of prior local therapy on overall survival in men with metastatic castration‐resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.
- Published in:
- International Journal of Urology, 2018, v. 25, n. 12, p. 1004, doi. 10.1111/iju.13837
- By:
- Publication type:
- Article
Impact of prior local therapy on overall survival in men with metastatic castration‐resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital.
- Published in:
- International Journal of Urology, 2018, v. 25, n. 12, p. 998, doi. 10.1111/iju.13806
- By:
- Publication type:
- Article
Editorial Comment to Influence of prior oral ethinylestradiol use on the efficacy of enzalutamide for the treatment of castration‐resistant prostate cancer in men.
- Published in:
- International Journal of Urology, 2018, v. 25, n. 5, p. 471, doi. 10.1111/iju.13572
- By:
- Publication type:
- Article
Influence of prior oral ethinylestradiol use on the efficacy of enzalutamide for the treatment of castration‐resistant prostate cancer in men.
- Published in:
- International Journal of Urology, 2018, v. 25, n. 5, p. 464, doi. 10.1111/iju.13542
- By:
- Publication type:
- Article
Current treatment strategies for advanced prostate cancer.
- Published in:
- International Journal of Urology, 2018, v. 25, n. 3, p. 220, doi. 10.1111/iju.13512
- By:
- Publication type:
- Article
Baseline low serum dehydroepiandrosterone sulfate can predict poor responsiveness to hormone therapy in patients with hormone-naïve prostate cancer with skeletal metastases.
- Published in:
- International Journal of Urology, 2017, v. 24, n. 12, p. 861, doi. 10.1111/iju.13445
- By:
- Publication type:
- Article
Clinical development of immunotherapy for prostate cancer.
- Published in:
- International Journal of Urology, 2017, v. 24, n. 9, p. 675, doi. 10.1111/iju.13397
- By:
- Publication type:
- Article
IJU this issue.
- Published in:
- International Journal of Urology, 2017, v. 24, n. 8, p. 565, doi. 10.1111/iju.13427
- By:
- Publication type:
- Article
Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics Approach.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 1, p. 87, doi. 10.3390/biom14010087
- By:
- Publication type:
- Article
Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 11, p. 1590, doi. 10.3390/biom12111590
- By:
- Publication type:
- Article
Cyclin‐dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration‐resistant prostate cancer.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 5, p. 1, doi. 10.1002/ctm2.1678
- By:
- Publication type:
- Article
Androgen‐repressed lncRNA LINC01126 drives castration‐resistant prostate cancer by regulating the switch between O‐GlcNAcylation and phosphorylation of androgen receptor.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 1, p. 1, doi. 10.1002/ctm2.1531
- By:
- Publication type:
- Article
Positive epigenetic regulation loop between AR and NSUN2 promotes prostate cancer progression.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 9, p. 1, doi. 10.1002/ctm2.1028
- By:
- Publication type:
- Article
The driver role of JAK‐STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy‐ and castration‐resistant prostate cancer.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 8, p. 1, doi. 10.1002/ctm2.978
- By:
- Publication type:
- Article